BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36500603)

  • 1. Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells.
    Ianni A; Ruggeri P; Bellio P; Martino F; Celenza G; Martino G; Franceschini N
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling.
    Jiang B; Chen J; Xu L; Gao Z; Deng Y; Wang Y; Xu F; Shen X; Guo DA
    BMC Pharmacol; 2010 Aug; 10():10. PubMed ID: 20735854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
    Morini M; Mottolese M; Ferrari N; Ghiorzo F; Buglioni S; Mortarini R; Noonan DM; Natali PG; Albini A
    Int J Cancer; 2000 Aug; 87(3):336-42. PubMed ID: 10897037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
    Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
    Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
    Liu H; Zang C; Fenner MH; Possinger K; Elstner E
    Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
    Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
    Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
    Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
    Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
    Sen T; Dutta A; Chatterjee A
    Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
    Canning MT; Postovit LM; Clarke SH; Graham CH
    Exp Cell Res; 2001 Jul; 267(1):88-94. PubMed ID: 11412041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
    J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of breast cancer cells MDA-MB-231 invasion by di(2-ethylhexyl)phthalate through matrix metalloproteinase-2/-9 overexpression.
    Zhang S; Ma J; Fu Z; Zhang Z; Cao J; Huang L; Li W; Xu P; Cao X
    Environ Sci Pollut Res Int; 2016 May; 23(10):9742-9. PubMed ID: 26850096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
    Magee PJ; Allsopp P; Samaletdin A; Rowland IR
    Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
    You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
    Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaprozin: A new hope in the modulation of matrix metalloproteinase 9 activity.
    Ianni A; Celenza G; Franceschini N
    Chem Biol Drug Des; 2019 May; 93(5):811-817. PubMed ID: 30582279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.